Equities

Third Age Health Services Ltd

TAH:NZC

Third Age Health Services Ltd

Actions
Health CareHealth Care Providers
  • Price (NZD)1.69
  • Today's Change-0.02 / -1.17%
  • Shares traded1.26k
  • 1 Year change+9.03%
  • Beta--
Data delayed at least 20 minutes, as of Apr 26 2024 04:50 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Third Age Health Services Limited is a New Zealand-based provider with a special focus on the health and wellbeing of older people living in aged residential care and in the community. The Company is engaged in providing health care services for older people, including those living in retirement villages, private hospitals, secure dementia units as well as in communities across New Zealand. The Company’s segments include the aged medical residential care services segment, which is engaged in the provision of medical care services to the aged care sector and general practice medical services. It provides onsite clinics, rostered rounds, and after-hours on-call healthcare services. Its subsidiaries include Hawkes Bay Wellness Centre Limited, Belmont Medical Centre Limited, Ponsonby Medical (Third Age Health) Limited, and Third Age Employee Share Purchase Plan Trust.

  • Revenue in NZD (TTM)13.98m
  • Net income in NZD632.00k
  • Incorporated2010
  • Employees--
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
TAH:NZC since
announced
Transaction
value
Hub Aged Care LtdAnnounced05 Mar 202405 Mar 2024Announced3.05%426.00k
Data delayed at least 20 minutes, as of Apr 26 2024 04:50 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.